[1] Sheiner, L.B.; Rosenberg, B.; Marathe, V.V. J. Pharmacokinet Biopharm. 1977, 5: 445–479.
[2] Roy A., Ette E.I. AAPS J. 2005, 7(2): E408–E420.
[3] Retout, S.; Mentré, F. J. Biopharm. Stat. 2003, 13(2): 209–227.
[4] Holford, N.H.G.; Kimko, H.C.; Monteleone, J.P.R.; Peck,C.C. Annu. Rev. Pharmacol. Toxicol. 2000, 40: 209–234.
[5] Wu, K.H.; Cui, Y.M.; Guo, J.F.; Zhou, Y.; Zhai, S.D.; Cui,F.D.; Lu, W. Drug Metab. Dispos. 2005, 33(9): 1268–1275.
[6] Oellerich, M.; Armstrong, V.W.; Kahan, B.D.; Shaw, L.; Holt, D.W.; Yatscoff, R.; Lindholm, A.; Halloran, P.; Gallicano, K.; Wonigeit, K. Ther. Drug Monit. 1995, 17: 642–654.
[7] Belitsky, P.; Dunn, S.; Jonhston, A.; Johnston, A.; Levy, G. Clin. Pharmacokinet. 2000, 39: 117–125.
[8] Dunn, C.J.; Wagstaff, A.J.; Perry, C.M.; Perry, C.M.; Plosker, G.L.; Goa, K.L. Drugs. 2001, 61: 1957–2016.
[9] Irtan, S.; Saint-Marcoux, F.; Rousseau, A.; Zhang, D.; Leroy, V.; Marquet, P.; Jacqz-Aigrain, E. Ther. Drug Monit. 2007, 29: 96–102.
[10] Rousseau, A.; Leger, F.; LeMeur, Y.; Saint-Marcoux, F.; Paintaud, G.; Buchler, M.; Marquet, P. Ther. Drug Monit. 2004, 26: 23–30.
[11] Tokui, K.; Kimata, T.; Uchida, K.; Yuasa, H.; Hayashi, Y.; Itatsu, T.; Nabeshima, T. Ther. Drug Monit. 2004, 26: 287–294.
[12] Beal, S.L.; Sheiner, L.B. NONMEM Users Guide. NONMEM Project Group, University of California, San Francisco, CA, 1989.
[13] Hooker, A.; Vicini, P. AAPS J. 2005, 7(4): E759–E785.
[14] Turner, P.K.; Iacono, L.C.; Panetta, J.C.; Santana, V.M.; Daw, N.C.; Gajjar, A.; Stewart, C.F. Cancer Chemother. Pharmacol. 2006, 57: 475–482.